| 1. |
Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci, 2001, 56(3): M146-M156.
|
| 2. |
Kelaiditi E, Cesari M, Canevelli M, et al. Cognitive frailty: rational and definition from an (I.A.N.A./I.A.G.G.) international consensus group. J Nutr Health Aging, 2013, 17(9): 726-734.
|
| 3. |
Panza F, D’Introno A, Colacicco AM, et al. Cognitive frailty: predementia syndrome and vascular risk factors. Neurobiol Aging, 2006, 27(7): 933-940.
|
| 4. |
Ruan Q, Yu Z, Chen M, et al. Cognitive frailty, a novel target for the prevention of elderly dependency. Ageing Res Rev, 2015, 20: 1-10.
|
| 5. |
Feng L, Zin Nyunt MS, Gao Q, et al. Cognitive frailty and adverse health outcomes: findings from the Singapore Longitudinal Ageing Studies (SLAS). J Am Med Dir Assoc, 2017, 18(3): 252-258.
|
| 6. |
Feng L, Nyunt MS, Gao Q, et al. Physical Frailty, Cognitive impairment, and the risk of neurocognitive disorder in the Singapore Longitudinal Ageing Studies. J Gerontol A Biol Sci Med Sci, 2017, 72(3): 369-375.
|
| 7. |
Roppolo M, Mulasso A, Rabaglietti E. Cognitive frailty in Italian community-dwelling older dults: prevalence rate and its association with disability. J Nutr Health Aging, 2017, 21(6): 631-636.
|
| 8. |
Solfrizzi V, Scafato E, Seripa D, et al. Reversible cognitive frailty, dementia, and all-cause mortality. The Italian longitudinal study on aging. J Am Med Dir Assoc,, 2017, 18: 89.e1-89.e8.
|
| 9. |
Hao Q, Dong B, Yang M, et al. Frailty and cognitive impairment in predicting mortality among oldest-old people. Front Aging Neurosci, 2018, 10: 295.
|
| 10. |
Cho NH, Shaw JE, Karuranga S, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract, 2018, 138: 271-281.
|
| 11. |
Wang L, Gao P, Zhang M, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA, 2017, 317(24): 2515-2523.
|
| 12. |
Koekkoek PS, Kappelle LJ, van den Berg E, et al. Cognitive function in patients with diabetes mellitus: guidance for daily care. Lancet Neurol, 2015, 14(3): 329-340.
|
| 13. |
Jang HC. Sarcopenia, frailty, and diabetes in older adults. Diabetes Metab J, 2016, 40(3): 182-189.
|
| 14. |
Castrejón-Pérez RC, Gutiérrez-Robledo LM, Cesari M, et al. Diabetes mellitus, hypertension and frailty: a population-based, cross-sectional study of Mexican older adults. Geriatr Gerontol Int, 2017, 17(6): 925-930.
|
| 15. |
Fukazawa R, Hanyu H, Sato T, et al. Subgroups of Alzheimer’s disease associated with diabetes mellitus based on brain imaging. Dement Geriatr Cogn Disord, 2013, 35(5/6): 280-290.
|
| 16. |
Hirose D, Hanyu H, Fukasawa R, et al. Frailty in diabetes-related dementia. Geriatr Gerontol Int, 2016, 16(5): 653-655.
|
| 17. |
Thein FS, Li Y, Nyunt MSZ, et al. Physical frailty and cognitive impairment is associated with diabetes and adversely impact functional status and mortality. Postgrad Med, 2018, 130(6): 561-567.
|
| 18. |
Houles M, Canevelli M, van Kan GA, et al. Frailty and cognition. J Frailty Aging, 2012, 1(2): 56-63.
|
| 19. |
Robertson DA, Savva GM, Kenny RA. Frailty and cognitive impairment--a review of the evidence and causal mechanisms. Ageing Res Rev, 2013, 12(4): 840-851.
|
| 20. |
Nishiguchi S, Yamada M, Fukutani N, et al. Differential association of frailty with cognitive decline and sarcopenia in community-dwelling older adults. J Am Med Dir Assoc, 2015, 16(2): 120-124.
|
| 21. |
Zilliox LA, Chadrasekaran K, Kwan JY, et al. Diabetes and cognitive impairment. Curr Diab Rep, 2016, 16(9): 87.
|
| 22. |
Park SW, Goodpaster BH, Strotmeyer ES, et al. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care, 2007, 30(6): 1507-1512.
|
| 23. |
Morley JE, Malmstrom TK, Rodriguez-Mañas L, et al. Frailty, sarcopenia and diabetes. J Am Med Dir Assoc, 2014, 15(12): 853-859.
|
| 24. |
Chang KV, Hsu TH, Wu WT, et al. Association between sarcopenia and cognitive impairment: a systematic review and meta-analysis. J Am Med Dir Assoc, 2016, 17(12): 1164.e7-1164.e15.
|
| 25. |
Serra-Prat M, Palomera E, Clave P, et al. Effect of age and frailty on ghrelin and cholecystokinin responses to a meal test. Am J Clin Nutr, 2009, 89(5): 1410-1417.
|
| 26. |
Tuttle LJ, Sinacore DR, Cade WT, et al. Lower physical activity is associated with higher intermuscular adipose tissue in people with type 2 diabetes and peripheral neuropathy. Phys Ther, 2011, 91(6): 923-930.
|
| 27. |
Cesari M, Penninx BW, Pahor M, et al. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci, 2004, 59(3): 242-248.
|
| 28. |
Bree AJ, Puente EC, Daphna-Iken D, et al. Diabetes increases brain damage caused by severe hypoglycemia. Am J Physiol Endocrinol Metab, 2009, 297(1): E194-E201.
|
| 29. |
Abdelhafiz AH, Rodríguez-Mañas L, Morley JE, et al. Hypoglycemia in older people - a less well recognized risk factor for frailty. Aging Dis, 2015, 6(2): 156-167.
|
| 30. |
Abdelhafiz AH, Sinclair AJ. Cognitive frailty in older people with type 2 diabetes mellitus: the central role of hypoglycaemia and the need for prevention. Curr Diab Rep, 2019, 19(4): 15.
|
| 31. |
Sinclair AJ, Girling AJ, Bayer AJ. Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. All Wales Research into Elderly (AWARE) study. Diabetes Res Clin Pract, 2000, 50(3): 203-212.
|
| 32. |
de Galan BE, Zoungas S, Chalmers J, et al. Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia, 2009, 52(11): 2328-2336.
|
| 33. |
Li Y, Zou Y, Wang S, et al. A pilot study of the FRAIL scale on predicting outcomes in Chinese elderly people with type 2 diabetes. J Am Med Dir Assoc, 2015, 16(8): 714.e7-714.e12.
|
| 34. |
Cacciatore F, Testa G, Galizia G, et al. Clinical frailty and long-term mortality in elderly subjects with diabetes. Acta Diabetol, 2013, 50(2): 251-260.
|
| 35. |
Ng TP, Feng L, Nyunt MS, et al. Nutritional, physical, cognitive, and combination interventions and frailty reversal among older adults: a randomized controlled trial. Am J Med, 2015, 128(11): 1225-1236.e1.
|
| 36. |
Ngandu T, Lehtisalo J, Solomon A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet, 2015, 385(9984): 2255-2263.
|
| 37. |
Rejeski WJ, Bray GA, Chen SH, et al. Aging and physical function in type 2 diabetes: 8 years of an intensive lifestyle intervention. J Gerontol A Biol Sci Med Sci, 2015, 70(3): 345-353.
|
| 38. |
Bonds DE, Miller ME, Dudl J, et al. Severe hypoglycemia symptoms, antecedent behaviors, immediate consequences and association with glycemia medication usage: secondary analysis of the ACCORD clinical trial data. BMC Endocr Disord, 2012, 12: 5.
|
| 39. |
Lipska KJ, Krumholz H, Soones T, et al. Polypharmacy in the aging patient: a review of glycemic control in older adults with type 2 diabetes. JAMA, 2016, 315(10): 1034-1045.
|
| 40. |
Sinclair AJ, Abdelhafiz A, Dunning T, et al. An international position statement on the management of frailty in diabetes mellitus: summary of recommendations 2017. J Frailty Aging, 2018, 7(1): 10-20.
|
